Lv3
236 积分 2023-01-03 加入
Study Design of AOC 1001-CS1, a Phase 1/2 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Patients with Myotonic Dystrophy Type 1 (DM1) (MARINA) (S23.006)
2小时前
求助中
225P Initial data from the DELIVER trial of DYNE-251 in males with DMD Mutations amenable to Exon 51 skipping
3小时前
已完结
Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeutics
13天前
已完结
抗体-寡核苷酸偶联物研究现状
29天前
已完结
Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
1个月前
已完结
Data point weighting in pharmacokinetic analysis: intravenous paracetamol in man
2个月前
已完结
〈1106〉 Immunogenicity Assays—Design and Validation of Immunoassays to Detect Anti-Drug Antibodies
2个月前
已关闭
Absorption, metabolism and excretion of once-weekly somapacitan, a long-acting growth hormone derivative, after single subcutaneous dosing in human subjects
4个月前
已完结
Engineering of a Pichia pastoris Expression System for High-Level Secretion of HSA/GH Fusion Protein
4个月前
已完结
Identification and differentiation of somapacitan, a long-acting growth hormone derivative, and recombinant human growth hormone in equine plasma by LC-HRMS for doping control purpose
4个月前
已完结
皖公网安备34019202002308
